Want to see TSE:MDP full AI Analyst Report?
Medexus Pharmaceuticals Inc (MDP) Income Statement
Medexus Pharmaceuticals Inc Income Statement
Last quarter (Q1 2027), Medexus Pharmaceuticals Inc's total revenue was $28.59M, an increase of 16.13% from the same quarter last year. In Q1, Medexus Pharmaceuticals Inc's net income was $547.66K. See Medexus Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| $ 99.33M | $ 113.05M | $ 108.10M | $ 76.70M | $ 79.66M | |
| $ 54.41M | $ 59.51M | $ 60.04M | $ 37.93M | $ 42.01M | |
| $ 48.58M | $ 48.72M | $ 52.42M | $ 50.30M | $ 43.38M | |
| Depreciation and Amortization | $ 9.73M | $ 5.81M | $ 6.08M | $ 6.14M | $ 5.98M |
| $ 12.66M | $ 19.28M | $ 14.65M | $ 14.55M | $ -15.71M | |
| $ 5.83M | $ 10.79M | $ 7.61M | $ -12.38M | $ -1.38M | |
| $ -8.11M | $ -10.69M | $ -12.65M | $ 8.56M | $ -30.13M | |
| $ -2.27M | $ 106.00K | $ -5.04M | $ -3.82M | $ -31.50M | |
| $ -2.39M | $ -214.00K | $ 1.22M | $ -2.88M | $ -28.26M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.07 | $ -0.01 | $ 0.08 | $ -0.19 | $ -1.86 |
| Diluted EPS | $ -0.07 | $ -0.01 | $ 0.08 | $ -0.19 | $ -1.86 |
| Weighted Average Shares Outstanding | 32.32M | 22.32M | 19.98M | 19.45M | 15.20M |
| Weighted Average Shares Outstanding (Diluted) | 32.32M | 22.49M | 20.52M | 19.86M | 15.20M |
Currency in USD